GSA Capital Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,758
| Closed | -$567K | – | 1749 |
|
|
2025
Q4 | $567K | Buy |
+2,758
| New | +$519K | 0.05% | 728 |
|
|
2025
Q3 | – | Sell |
-6,760
| Closed | -$1.14M | – | 1682 |
|
|
2025
Q2 | $1.14M | Buy |
+6,760
| New | +$1M | 0.08% | 376 |
|
|
2024
Q4 | – | Sell |
-25,506
| Closed | -$2.82M | – | 1636 |
|
|
2024
Q3 | $2.82M | Buy |
25,506
+11,883
| +87% | +$1.24M | 0.21% | 46 |
|
|
2024
Q2 | $1.34M | Buy |
13,623
+11,781
| +640% | +$1.2M | 0.09% | 326 |
|
|
2024
Q1 | $206K | Sell |
1,842
-24,627
| -93% | -$2.66M | 0.02% | 1398 |
|
|
2023
Q4 | $2.67M | Buy |
26,469
+23,635
| +834% | +$2.34M | 0.22% | 52 |
|
|
2023
Q3 | $246K | Buy |
+2,834
| New | +$256K | 0.02% | 1188 |
|
|
2021
Q1 | – | Sell |
-9,889
| Closed | -$530K | – | 1122 |
|
|
2020
Q4 | $530K | Buy |
+9,889
| New | +$513K | 0.09% | 395 |
|
|
2020
Q2 | – | Sell |
-19,014
| Closed | -$912K | – | 664 |
|
|
2020
Q1 | $912K | Sell |
19,014
-4,629
| -20% | -$240K | 0.23% | 27 |
|
|
2019
Q4 | $1.2M | Buy |
23,643
+17,380
| +278% | +$898K | 0.14% | 132 |
|
|
2019
Q3 | $296K | Buy |
+6,263
| New | +$286K | 0.04% | 897 |
|
|
2019
Q2 | – | Sell |
-49,202
| Closed | -$2.37M | – | 1453 |
|
|
2019
Q1 | $2.37M | Buy |
49,202
+23,591
| +92% | +$1.18M | 0.24% | 49 |
|
|
2018
Q4 | $1.14M | Buy |
+25,611
| New | +$1.33M | 0.13% | 164 |
|
|
2018
Q3 | – | Sell |
-37,684
| Closed | -$1.84M | – | 1646 |
|
|
2018
Q2 | $1.84M | Buy |
+37,684
| New | +$2.14M | 0.09% | 321 |
|
|
2017
Q2 | – | Sell |
-4,833
| Closed | -$394K | – | 1692 |
|
|
2017
Q1 | $394K | Buy |
+4,833
| New | +$380K | 0.02% | 1230 |
|
|
2016
Q4 | – | Sell |
-5,879
| Closed | -$457K | – | 1757 |
|
|
2016
Q3 | $457K | Sell |
5,879
-8,103
| -58% | -$655K | 0.02% | 1111 |
|
|
2016
Q2 | $1.09M | Sell |
13,982
-9,320
| -40% | -$743K | 0.06% | 575 |
|
|
2016
Q1 | $1.91M | Buy |
23,302
+14,426
| +163% | +$1.17M | 0.12% | 199 |
|
|
2015
Q4 | $792K | Sell |
8,876
-31,955
| -78% | -$2.71M | 0.04% | 866 |
|
|
2015
Q3 | $3.14M | Sell |
40,831
-126,916
| -76% | -$10.6M | 0.15% | 107 |
|
|
2015
Q2 | $14M | Buy |
167,747
+141,572
| +541% | +$12.5M | 0.54% | 4 |
|
|
2015
Q1 | $2.36M | Sell |
26,175
-35,710
| -58% | -$3.07M | 0.09% | 255 |
|
|
2014
Q4 | $5M | Buy |
61,885
+57,164
| +1,211% | +$4.51M | 0.35% | 13 |
|
|
2014
Q3 | $354K | Sell |
4,721
-10,057
| -68% | -$732K | 0.02% | 1150 |
|
|
2014
Q2 | $1.01M | Sell |
14,778
-23,539
| -61% | -$1.6M | 0.05% | 670 |
|
|
2014
Q1 | $2.68M | Buy |
38,317
+16,778
| +78% | +$1.17M | 0.19% | 101 |
|
|
2013
Q4 | $1.44M | Buy |
21,539
+12,055
| +127% | +$737K | 0.11% | 187 |
|
|
2013
Q3 | $495K | Sell |
9,484
-31,964
| -77% | -$1.62M | 0.04% | 803 |
|
|
2013
Q2 | $1.96M | Buy |
+41,448
| New | +$1.89M | 0.23% | 71 |
|
Other funds holding CAH
VCM
VPM
GSA Capital Partners's CAH Position: Q1 2026 in Review
GSA Capital Partners sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 2,758 shares — an estimated $567K sold.
GSA Capital Partners first reported a position in CAH in Q2 2013 and held it in 29 quarters. The position peaked at $14M in Q2 2015. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- GSA Capital Partners reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 2,758 Cardinal Health shares in Q1 2026, an estimated $567K.
- GSA Capital Partners first reported a position in Cardinal Health in Q2 2013 and held it in 29 quarters.
- GSA Capital Partners's Cardinal Health position peaked at $14M in Q2 2015.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.